CRISPR Therapeutics AG Common Shares (CRSP) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for CRISPR Therapeutics AG Common Shares, updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
CRISPR Therapeutics AG Common Shares (CRSP) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $5.0B. It trades at $54.11, up 5.13% today. Its overall quality score is 47 out of 100, ranked against the whole US market. 13 analysts' average target of $71.17 implies +31.5% from today's price. Kronos AI's 30-day forecast is −3.0% (3 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $71.17 |
| Low – high | $45.00 – $110.00 |
| Analysts | 13 |
| Upside to average | +31.5% |
Kronos AI 30-day forecast
| Expected close | $49.91 (−3.0%) |
| Likely range | −5.1% … +1.5% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 10 |
| Solvency | 50 |
| Growth | 82 |
| Overall | 47 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator